TNF and rheumatoid arthritis: Humby et al. reported that RA patients that inadequately respond to TNFi, and that are classified as having histological and RNA sequencing-defined B-cell poor synovitis, are significantly more prone to have a successful treatment response to IL6R than TNF-α inhibition [29].